Normal view MARC view ISBD view

Helping diabetic students adjust to college. [electronic resource]

By:

Bontrager, F A

Contributor(s):

Producer: 19880729Description: 275-6 p. digitalISSN:

0145-7217

Subject(s):

Online resources:

Available from publisher's website

In: The Diabetes educator vol. 14

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Letter

There are no comments on this title.

to post a comment.

Back to results

1 Notch signaling regulates PD-1 expression during CD8(+) T-cell activation.
by Mathieu, Mélissa
2 Hoxb4 overexpression in CD4 memory phenotype T cells increases the central memory population upon homeostatic proliferation.
by Frison, Héloïse
3 Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy.
by Esfahani, Khashayar
4 New evidence for a role of allograft accommodation in long-term tolerance.
by Heslan, Jean Marie
5 Expression of heme oxygenase-1 in neural stem/progenitor cells as a potential mechanism to evade host immune response.
by Bonnamain, Virginie
6 Immunoregulatory function of IL-27 and TGF-β1 in cardiac allograft transplantation.
by Le Texier, Laetitia
7 The non-classical MAP kinase ERK3 controls T cell activation.
by Marquis, Miriam
8 Distinct tryptophan catabolism and Th17/Treg balance in HIV progressors and elite controllers.
by Jenabian, Mohammad-Ali
9 The C-type lectin-like receptor CLEC-1, expressed by myeloid cells and endothelial cells, is up-regulated by immunoregulatory mediators and moderates T cell activation.
by Thebault, Pamela
10 Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion.
by Dugast, Anne-Sophie
11 Innate immunity activation in the early brain injury period following subarachnoid hemorrhage.
by Gris, Typhaine
12 Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection.
by Ashton-Chess, Joanna
13 Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma.
by Jamal, Rahima